Skip to main content
An official website of the United States government

recombinant fowlpox-B7.1 vaccine

A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 (rF-B7.1) vaccine may enhance antigen presentation and activate antitumoral cytotoxic T-cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Abbreviation:rF-B7.1
rF-B7.1 vaccine
NSC code:679008
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search